BioSpace News Archive

Business

Terason Partners with AmCad BioMed Corporation to Provide More Efficient Solutions to Assess and Diagnose Obstructive Sleep Apnea

Terason, a leading global ultrasound imaging company based in Burlington, Mass., has partnered with AmCad BioMed Corporation to provide its ultrasound imaging technology for AmCad’s innovative Obstructive Sleep Apnea (OSA) solution, AmCAD®-UO.

December 18, 2019
·
2 min read
Deals

Alpha Holdings Files Shareholder Presentation on Opposition to Proposed China Grand Takeover of OncoSec

Details Unfavorable Deal Terms and Urges OncoSec Stockholders to Vote on the BLUE Proxy Card “AGAINST” the China Grand Takeover

December 18, 2019
·
4 min read
Pharm Country

Introducing Investors to Breakthrough Bio-tech Companies: Frost & Sullivan Releases Q3 Equity Research for Investors to Make Informed Decisions

Equity research is published in the framework of Frost’s Independent Equity Research Program.

December 18, 2019
·
2 min read
Business

Onconova Therapeutics Announces Exclusive License Agreement with Specialised Therapeutics for Rigosertib in Australia and New Zealand

Specialised Therapeutics receives exclusive license to commercialize rigosertib in Australia and New Zealand Onconova to be eligible to receive up to US $30.4 million in clinical, regulatory, and sales-based milestones and tiered double-digit royalties

December 18, 2019
·
6 min read
Drug Development

GSK announces positive headline results in phase 3 study of Benlysta in patients with lupus nephritis

BLISS-LN achieves primary endpoint and all major secondary endpoints

December 18, 2019
·
12 min read
Nordic Nanovector Awarded NOK 12 Million in Funding From the Norwegian Research Council to Advance Alpha37, a Targeted Alpha Therapy for B-cell Cancers

Nordic Nanovector ASA announces that its research and development project Nanoyield has received a non-dilutive funding of NOK 12 million from the Norwegian Research Council.

December 18, 2019
·
4 min read
Business

FerGene Appoints David Meek President and Chief Executive Officer

FerGene, a new gene therapy company launched by Ferring Pharmaceuticals and Blackstone Life Sciences in November, announced the appointment of David Meek as President and Chief Executive Officer, effective January 14, 2020.

December 18, 2019
·
6 min read
Deals

BrainStorm Issues 2019 Letter to Shareholders

BrainStorm Cell Therapeutics Inc., a leading developer of cellular therapeutics for neurodegenerative diseases, issued a Letter to Shareholders.

December 18, 2019
·
9 min read
Business

Grants awarded to oral and maxillofacial surgeons for volunteer service

The American Association of Oral and Maxillofacial Surgeons and the Henry Schein Cares Foundation are supporting the volunteer service of four oral and maxillofacial surgeons through the joint Global Outreach Program.

December 18, 2019
·
2 min read
Drug Development

OBI Pharma Announces Initiation of a Phase 1/2 Study of Its Antibody-Drug Conjugate (ADC) Targeted Cancer Therapy, OBI-999

OBI Pharma announced the initiation of a Phase 1/2 clinical trial of OBI-999, an antibody drug conjugate targeting Globo H, a glycolipid antigen overexpressed in multiple tumor types.

December 18, 2019
·
3 min read